JPRN-UMIN000001035已完成未知
Therapeutic efficacy of Pioglitazone for Non-Alcoholic Fatty Liver Desease(NAFLD) patients with impaired glucose tolerance or type 2 diabetes - TOPIC Study
Tohoku University Graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2008年2月15日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who did not consent to enroll to the study Patients with contraindication for pioglitazone Patients with malignant disease Others who are not suitable to enroll to the study from the physicians points of view
研究者
相似试验
已完成
4 期
Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)Nonalcoholic SteatohepatitisNCT00227110The University of Texas Health Science Center at San Antonio55
已完成
2 期
Study of efficacy and side effects of Pioglitazone in the treatment of psoriasisPsoriasis vulgarisPsoriasis.IRCT138903013862N2Research Council of Mashhad University of Medical Sciences26
招募中
不适用
Comparison of efficacy and safety of pioglitazone versus metformin for moderate-to-severe chronic plaque psoriasis in patients with prediabetes or newly-diagnosed diabetes who have never taken anti-diabetic agents: a parallel, randomized, open-label, prospective studypsoriasisprediabetesdiabetes mellitusplaquepsoriasisprediabetesdiabetes mellitusTCTR20190724005Dermatological Society of Thailand (pending)40
招募中
3 期
efficacy and safety of oral pioglitazone in treatment of lichen planopilarisichen planopilaris.Lichen planopilarisL66.1IRCT20230415057912N1Esfahan University of Medical Sciences30
进行中（未招募）
不适用
Effect of pioglitazone in patienst with Adrenomyeloneuropathy.X-linked adrenoleukodystrophyEUCTR2011-006113-34-ESAURORA PUJOL ONOFRE